協創數據(300857.SZ):入選先進製造業聯合總部基地遴選項目
格隆匯11月4日丨協創數據(300857.SZ)公佈,深圳市福田區工業和信息化局於2021年11月4日公示了《先進製造業聯合總部遴選方案》,經公開遴選及評審等環節,公司入選先進製造業聯合總部基地遴選項目意向用地單位。公示時間為2021年11月4日至2021年11月10日。
項目擬採用綠色建築技術,集約土地資源,按照垂直空間、完善產業鏈的設計標準,打造集總部辦公、研發為一體的先進製造業企業總部集聚樓宇,成為深圳市先進製造業產業空間,主要包括製造總部中心、研發中心、企業技術中心及國家級工程實驗室。公司持有約6225.6平方米。
公司表示,該次公司入選先進製造業聯合總部基地遴選項目,對公司擴大研發基地,提高研發實力有重要的意義,不影響公司經營的獨立性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.